Ascendis Pharma
ASND
#1287
Rank
A$24.90 B
Marketcap
A$379.69
Share price
-1.26%
Change (1 day)
15.43%
Change (1 year)

EPS for Ascendis Pharma (ASND)

EPS in 2026 (TTM): A$19.64

According to Ascendis Pharma 's latest financial reports the company's current EPS (TTM) is A$20.52. In 2025 the company made an earnings per share (EPS) of A-$6.44 an increase over its 2024 EPS that were of A-$10.69.

EPS history for Ascendis Pharma from 2023 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A$19.64-405.12%
2025A-$6.44-39.79%
2024A-$10.69-23.17%
2023A-$13.91

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Akebia Therapeutics
AKBA
A-$0.24-101.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Affimed
AFMD
A-$7.85-138.26%๐Ÿ‡ฉ๐Ÿ‡ช Germany
Advaxis
ADXS.defunct
A-$14.56-170.93%๐Ÿ‡บ๐Ÿ‡ธ USA